- Insider Monkey•3 hours ago
Like everyone else, successful investors make mistakes. Some of their top consensus picks, such as Valeant and SunEdison, have not done well during the last 12 months due to various reasons. Nevertheless, the data show successful investors’ consensus picks have done well on average. The top 30 mid-cap stocks (market caps between $1 billion and […]
- The Wall Street Journal•yesterday
Bayer and U.S. healthcare investor Versant Ventures plan to establish a stem-cell research company called BlueRock Therapeutics, with initial joint funding of $225 million.
- Motley Fool•yesterday
Inovio had a setback with its cervical dysplasia vaccine program, but the biotech also had a huge win this year.
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||75.28 - 76.95|
|52 Week Range||62.50 - 80.90|
|PE Ratio (TTM)||23.42|
|Dividend & Yield||3.35 (4.12%)|
|1y Target Est||N/A|